These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 32039440

  • 1. Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway.
    Cai F, Zhang Y, Li J, Huang S, Gao R.
    Biosci Rep; 2020 Mar 27; 40(3):. PubMed ID: 32039440
    [Abstract] [Full Text] [Related]

  • 2. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y, Zheng L, Liu J, Zhou Z, Cao X, Lv X, Chen F.
    Int Immunopharmacol; 2014 Aug 27; 21(2):447-55. PubMed ID: 24905636
    [Abstract] [Full Text] [Related]

  • 3. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
    Berrak O, Arisan ED, Obakan-Yerlikaya P, Coker-Gürkan A, Palavan-Unsal N.
    Apoptosis; 2016 Oct 27; 21(10):1158-78. PubMed ID: 27484210
    [Abstract] [Full Text] [Related]

  • 4. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM, Malik SN, Bedolla RG, Wang Y, Mikhailova M, Prihoda TJ, Troyer DA, Kreisberg JI.
    Endocr Relat Cancer; 2005 Mar 27; 12(1):119-34. PubMed ID: 15788644
    [Abstract] [Full Text] [Related]

  • 5. Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancer.
    Qi W, Morales C, Cooke LS, Johnson B, Somer B, Mahadevan D.
    Oncotarget; 2015 Dec 08; 6(39):41976-87. PubMed ID: 26506516
    [Abstract] [Full Text] [Related]

  • 6. Brassinin induces apoptosis in PC-3 human prostate cancer cells through the suppression of PI3K/Akt/mTOR/S6K1 signaling cascades.
    Kim SM, Park JH, Kim KD, Nam D, Shim BS, Kim SH, Ahn KS, Choi SH, Ahn KS.
    Phytother Res; 2014 Mar 08; 28(3):423-31. PubMed ID: 23686889
    [Abstract] [Full Text] [Related]

  • 7. [Kuwanon G inhibits growth, migration and invasion of gastric cancer cells by regulating the PI3K/AKT/mTOR pathway].
    Geng Z, Yang J, Niu M, Liu X, Shi J, Liu Y, Yao X, Zhang Y, Zhang X, Hu J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Aug 20; 44(8):1476-1484. PubMed ID: 39276043
    [Abstract] [Full Text] [Related]

  • 8. TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway.
    Vo BT, Morton D, Komaragiri S, Millena AC, Leath C, Khan SA.
    Endocrinology; 2013 May 20; 154(5):1768-79. PubMed ID: 23515290
    [Abstract] [Full Text] [Related]

  • 9. The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.
    Shorning BY, Dass MS, Smalley MJ, Pearson HB.
    Int J Mol Sci; 2020 Jun 25; 21(12):. PubMed ID: 32630372
    [Abstract] [Full Text] [Related]

  • 10. Tetrandrine suppresses metastatic phenotype of prostate cancer cells by regulating Akt/mTOR/MMP-9 signaling pathway.
    Kou B, Liu W, He W, Zhang Y, Zheng J, Yan Y, Zhang Y, Xu S, Wang H.
    Oncol Rep; 2016 May 25; 35(5):2880-6. PubMed ID: 26935264
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.
    Lv X, Li CY, Han P, Xu XY.
    Eur Rev Med Pharmacol Sci; 2018 Apr 25; 22(8):2321-2327. PubMed ID: 29762835
    [Abstract] [Full Text] [Related]

  • 12. Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer.
    Pungsrinont T, Kallenbach J, Baniahmad A.
    Int J Mol Sci; 2021 Oct 14; 22(20):. PubMed ID: 34681745
    [Abstract] [Full Text] [Related]

  • 13. Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways.
    Lu X, Yang F, Chen D, Zhao Q, Chen D, Ping H, Xing N.
    Int J Biol Sci; 2020 Oct 14; 16(7):1121-1134. PubMed ID: 32174789
    [Abstract] [Full Text] [Related]

  • 14. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells.
    Luo W, Liu Q, Jiang N, Li M, Shi L.
    Biosci Rep; 2019 Sep 30; 39(9):. PubMed ID: 31467176
    [Abstract] [Full Text] [Related]

  • 15. Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells.
    Zhou ZW, Li XX, He ZX, Pan ST, Yang Y, Zhang X, Chow K, Yang T, Qiu JX, Zhou Q, Tan J, Wang D, Zhou SF.
    Drug Des Devel Ther; 2015 Sep 30; 9():1511-54. PubMed ID: 25834399
    [Abstract] [Full Text] [Related]

  • 16. Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis.
    Sugawara T, Nevedomskaya E, Heller S, Böhme A, Lesche R, von Ahsen O, Grünewald S, Nguyen HM, Corey E, Baumgart SJ, Georgi V, Pütter V, Fernández-Montalván A, Vasta JD, Robers MB, Politz O, Mumberg D, Haendler B.
    Mol Oncol; 2024 Mar 30; 18(3):726-742. PubMed ID: 38225213
    [Abstract] [Full Text] [Related]

  • 17. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
    Kaarbø M, Mikkelsen OL, Malerød L, Qu S, Lobert VH, Akgul G, Halvorsen T, Maelandsmo GM, Saatcioglu F.
    Cell Oncol; 2010 Mar 30; 32(1-2):11-27. PubMed ID: 20203370
    [Abstract] [Full Text] [Related]

  • 18. Zingerone suppresses cell proliferation via inducing cellular apoptosis and inhibition of the PI3K/AKT/mTOR signaling pathway in human prostate cancer PC-3 cells.
    Qian S, Fang H, Zheng L, Liu M.
    J Biochem Mol Toxicol; 2021 Jan 30; 35(1):e22611. PubMed ID: 32905641
    [Abstract] [Full Text] [Related]

  • 19. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE, Shin JS, Leem DG, Kim SD, Cho WJ, Lee KT.
    Chem Biol Interact; 2016 Dec 25; 260():196-207. PubMed ID: 27720946
    [Abstract] [Full Text] [Related]

  • 20. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.
    Yan G, Ru Y, Wu K, Yan F, Wang Q, Wang J, Pan T, Zhang M, Han H, Li X, Zou L.
    Prostate; 2018 Feb 25; 78(3):166-177. PubMed ID: 29181846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.